ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Safety and Clinical Activity of Belantamab Mafodotin With Pembrolizumab in Pts With R/R MM: DREAMM-4 Study
By
ASCO 2022 Conference Coverage
FEATURING
Attaya Suvannasankha
By
ASCO 2022 Conference Coverage
FEATURING
Attaya Suvannasankha
Login to view comments.
Click here to Login
